The Effects of COVID-19 on Skeletal Muscles, Muscle Fatigue and Rehabilitation Programs Outcomes
Overview
Authors
Affiliations
: Consequences due to infection with SARS-CoV-2 virus can have a direct impact on skeletal muscle, due to the fact that both cardiac and skeletal muscle tissue show robust ACE2(angiotensin-converting enzyme 2) expression, suggesting a potential susceptibility to SARS-CoV-2 infection in both types of tissues. From the articles analyzed we concluded that the musculoskeletal damage is firstly produced by the inflammatory effects, cytokine storm and muscle catabolism. However, myopathy, polyneuropathy and therapies such as corticoids were also considered important factors in muscle fatigue and functional incapacity. Pulmonary rehabilitation programs and early mobilization had a highly contribution during the acute phase and post-illness recovery process and helped patients to reduce dyspnea, increase the capacity of physical effort, overcome psychological disorders and improved the quality of their life. : We have included in this review 33 articles that contain data on muscle damage following SARS-CoV-2 infection. We used the following keywords to search for articles: SARS-CoV-2, COVID-19, muscle weakness, muscle disease, muscle fatigue, neurological disorders. As a search strategy we used PubMed, Cochrane Database of Systematic Reviews; Database of Abstracts of Reviews of Effects and Health Technology Assessment Database to collect the information. We also have chosen the most recent articles published in the last 5 years. : Muscular damage, as well as the decrease in the quality of life, are often a consequence of severe SARS-CoV-2 infection through: systemic inflammation, corticotherapy, prolonged bed rest and other unknown factors. Pulmonary rehabilitation programs and early mobilization had a highly contribution during the acute phase and post-illness recovery process and helped patients to reduce dyspnea, increase the capacity of physical effort, overcome psychological disorders and improve the quality of their life.
Gonda K, Hai T, Suzuki K, Ozaki A, Shibusa T, Takenoshita S Nutrients. 2025; 17(2.
PMID: 39861420 PMC: 11767592. DOI: 10.3390/nu17020290.
Bereda G Ann Med Surg (Lond). 2024; 86(12):7318-7321.
PMID: 39649935 PMC: 11623843. DOI: 10.1097/MS9.0000000000000990.
Nagano M, Kabayama M, Ohata Y, Kido M, Rakugi H, Kamide K Geriatr Gerontol Int. 2024; 24(10):1060-1066.
PMID: 39215478 PMC: 11503560. DOI: 10.1111/ggi.14976.
Long-term impact of SARS-CoV-2 infection on cardiorespiratory fitness: a meta-analysis.
Chuatrakoon B, Konghakote S, Sa-Nguanmoo P, Nantakool S Front Public Health. 2023; 11:1215486.
PMID: 37920575 PMC: 10619755. DOI: 10.3389/fpubh.2023.1215486.
Abdelwahab S, Taha M, Aldhahi M Eur J Med Res. 2023; 28(1):434.
PMID: 37833811 PMC: 10571379. DOI: 10.1186/s40001-023-01402-1.